16 Aug Telemedicine 2.0: How Is It Relevant to Me
Description
The Telemedicine 2.0 series offers inter-disciplinary insights into telemedicine practice and development of its supporting technologies with consideration for the associated regulatory, data security, and patient privacy issues. This free online series will be hosted in six parts (one pre-recorded and five live sessions) in September and October. One registration will give you access to the all of the sessions.
If you’re curious about telemedicine, remote patient monitoring, or remote therapeutic monitoring in patient care, we will post a short video below by September 11 to describe what you can expect from this webinar series.
Series Learning Objectives
Upon completion of this program, participants will be able to:
- Identify opportunities to improve remote patient care
- Identify security and privacy risks associated with telemedicine technologies
- Mitigate introduction of disparities in access to clinical care
Sessions
- Telemedicine 2.0: How Is It Relevant to Me? (Pre-recorded video posted above by 09.11.24)
- Telemedicine Then and Now (09.25.24, 9–10am PDT)
- Telemedicine Regulatory Issues: Licensing, Standards of Practice, Billing, and Reimbursement (10.01.24, 3–4pm PDT)
- Protecting Privacy and Maintaining Security in Telemedicine (10.08.24, 3–4pm PDT)
- The Entrepreneur’s Perspective on Telemedicine Technology and Tools Development (10.15.24, 3–4pm PDT)
- Digital Inclusion and Access to Care by Telemedicine (10.24.24, 10–11am PDT)
About the Speaker
Teddy Johnson, PE, MBA, joined the healthcare community over 25 years ago, after graduating from Stanford University’s mechanical engineering program. Since then, he has served start-up and Fortune 500 companies in research, design, clinical, marketing, and sales leadership roles; developing imaging, interventional, surgical, and pharmaceutical products. Along the way, Teddy earned his MBA from the University of Michigan’s Ross Business School. With hard work, good judgment, and a little luck, Teddy has celebrated 2 IPO’s and 4 acquisitions, while earning numerous patents and commercializing dozens of new products worldwide. As a way of fostering innovation, Teddy teaches in the STEM and Biomedical Regulatory Affairs Master of Science (BRAMS) Programs at the University of Washington, serves as Director of Technology Development for the Institute of Translational Health Sciences and WE-REACH, and mentors startup CEOs in Seattle and the Silicon Valley.
Please sign in below to access this form.
Access to this form is restricted to ITHS Members. Please sign in, or create an account.
